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Abstract: Scc4 is an unusual bi-functional protein from Chlamydia trachomatis (CT) that functions
as a type III secretion system (T3SS) chaperone and an RNA polymerase (RNAP)-binding protein.
Both functions require interactions with protein partners during specific stages of the CT developmental
cycle. As a T3SS chaperone, Scc4 binds Scc1 during the late stage of development to form a heterodimer
complex, which chaperones the essential virulence effector, CopN. During the early-middle stage of
development, Scc4 regulates T3SS gene expression by binding the σ66 -containing RNAP holoenzyme.
In order to study the structure and association mechanism of the Scc4:Scc1 T3SS chaperone complex
using nuclear magnetic resonance (NMR) spectroscopy, we developed an approach to selectively
label each chain of the Scc4:Scc1 complex with the 15 N-isotope. The approach allowed one protein to
be visible in the NMR spectrum at a time, which greatly reduced resonance overlap and permitted
comparison of the backbone structures of free and bound Scc4. 1 H,15 N-heteronuclear single quantum
coherence spectra of the 15 N-Scc4:Scc1 and Scc4:15 N-Scc1 complexes showed a total structural
rearrangement of Scc4 upon binding Scc1 and a dynamic region isolated to Scc1, respectively.
Development of the chain-selective labeling approach revealed that the association of Scc4 and Scc1
requires partial denaturation of Scc1 to form the high affinity complex, while low affinity interactions
occurred between the isolated proteins under non-denaturing conditions. These results provide new
models for Scc40 s functional switching mechanism and Scc4:Scc1 association in CT.
Keywords: type III secretion; chaperone; transcription; Chlamydia trachomatis; NMR; Scc4; Scc1;
selective isotopic labeling

1. Introduction
Chlamydia trachomatis (CT) is a gram-negative, obligate intracellular bacterial pathogen with
distinct biovars that cause the most common sexually transmitted bacterial diseases or infectious
blindness due to trachoma, a neglected infectious disease [1,2]. CT utilizes a type three secretion system
(T3SS) to establish and maintain infection by delivering over 100 effector proteins into the host epithelial
cell [3–6]. Once the bacteria enter the host cell, they localize in a specialized membrane-surrounded
vacuole, termed an inclusion, where the effector proteins defend against the host’s immune response
and provide critical nutrients from the host cell. CT undergoes a unique, biphasic developmental cycle
within the inclusions from infectious elemental bodies (EBs) to noninfectious, vegetative reticulate
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bodies (RBs). RBs transit back to EBs prior to release of EBs from the host cell to reinitiate new infections.
The T3SS and transcriptional control of the developmental cycle are essential for infection, and Scc4
(specific chlamydia chaperone 4, formerly CT663, UniprotKB O84670) is a bi-functional protein with
implications to both systems.
Scc4 switches between two functions that depend on different protein-protein interactions at
specific stages
of the2020,
developmental
cycle with impacts on chlamydial development,2CopN
secretion,
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and selective gene expression [7]. A model of these protein-protein interactions is shown in Figure 1.
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In the present study, an approach to produce chain-selectively labeled Scc4:Scc1 complexes was
developed and used to compare the 3-dimensional backbone structure and dynamics of free and
Scc1-bound Scc4 and to study the mechanisms of Scc4 and Scc1 association. The NMR resonance
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assignments (1 H, 13 C, and 15 N) of Scc4 revealed a dynamic protein [18], but the investigation of
the Scc4:Scc1 complex using NMR is more difficult due to its larger size (33.5 kDa) and resonance
overlapping. For the structural studies of protein complexes, isotopic labelling of selected segments
or chains of a protein greatly reduces the overlap [19,20]. We tested several methods to produce
the chain-selectively labeled Scc4:Scc1 complex, where only one protein is isotopically labeled and
visible in the NMR spectrum at a time. Through these tests, we reveal new information about the
functional switching mechanism of Scc4, association of Scc4 and Scc1, and the total backbone structural
rearrangement of Scc4 upon binding Scc1.
2. Materials and Methods
2.1. Materials
The protein expressions were conducted using the previously reported recombinant expression
vectors of pACYCHis6 -Scc1, pET28Scc4, and pCDFScc4 [16]. The proteins that are encoded in these
vectors correspond to Scc1 with an N-terminal His6 -tag (His6 -Scc1), Scc4, and Scc4 with an N-terminal
His6 -tag (His6 -Scc4), respectively. The plasmid pScc1-FT [21] was generously gifted by Dr. Ken Fields
(University of Kentucky, College of Medicine, Lexington, KY, USA), which encodes Scc1 with a
C-terminal FLAG tag (Scc1-FLAG) [22]. Millipore Direct-Q 3 ultrapure water system was used as the
water source.
2.2. General Protocols
Centrifugal filters with a molecular weight cutoff of 10 kDa were used to exchange protein
sample buffer and concentrate samples prior to analysis. For exchanging the buffer, the samples were
concentrated to 0.25–0.5 mL and diluted to 4 mL at least 4 times. Purified protein samples were
stored at −20 ◦ C and concentrated to 0.35–0.5 mM immediately before NMR analysis. The Pierce
Coomassie (Bradford) Plus protein assay kit was used to determine protein concentrations following
the manufacturers 96-well plate procedure. Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) analysis was performed by mixing equal volumes of the samples with 2X Laemmli buffer
with 5% β-mercaptoethanol (v/v), heating at 85−95 ◦ C for 3 min, and running on a 4–20% Tris/glycine
gel at 120 V for 60 min in running buffer (25 mM tris (hydroxymethyl) aminomethane hydrochloride
(Tris), 192 mM glycine, 0.1% SDS, pH 8.3). Native gel analysis was performed by mixing the sample
with equal volumes of 2X native sample buffer (62.5 mM Tris, 40% glycerol, 0.01% bromophenol
blue (w/v)) and running on a 4–20% Tris/glycine gel at 120 V for 60 min in running buffer (25 mM
Tris, 192 mM glycine, pH 8.3). All gels were stained in brilliant blue R-250 solution (1.0 g/L brilliant
blue R-250 dye, 50% methanol, 40% water, and 10% acetic acid) for 1 h. After de-staining in 50%
water, 40% methanol, 10% acetic acid, the gels were imaged using a Bio-Rad Gel Doc EZ System.
Nickel immobilized affinity chromatography (Ni-IMAC) was performed using a fast protein liquid
chromatography system, 1–4 mL of nickel-charged resin in a 1 cm inner diameter column, absorbance
detection at 280 nm, and a fraction collector. The flow rate was 1 mL/min for sample loading and
2 mL/min for wash and elution steps. Wash steps were performed using 20 mL of Tris or phosphate
buffer. Tris buffer is 20 mM Tris, 300 mM NaCl, 2 mM imidazole, and 5% (w/v) glycerol at pH 8.0.
Phosphate buffer is 50 mM sodium phosphate, 300 mM NaCl, 2 mM imidazole, and 5% glycerol (w/v)
at pH 8.0. Elution steps were performed with 10 mL of 0.5% sarkosyl (sodium lauryl sarcosinate:
a non-denaturing detergent) in Tris buffer or 500 mM imidazole in Tris or phosphate buffer. Qualitative
size exclusion chromatography (SEC) was performed using a fast protein liquid chromatography
system with a ProteoSEC 16/60 3-70 HR column, NMR buffer, 2 mL/min flow rate, absorbance detection
at 280 nm, and a fraction collector. NMR buffer is 50 mM sodium phosphate, 10 mM of dithiothreitol
(DTT), pH 7.3.
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2.3. Protein Expression and Purification
The in vivo-associated complexes, Scc4:His6 -Scc1 and His6 -Scc4:Scc1-FLAG, were expressed and
purified as described by Ukwaththage, et al. [22]. Briefly, Scc4 and His6 -Scc1 were co-expressed from the
pET28Scc4 and pACYCHis6 -Scc1 vectors in E. coli BL21-Gold (DE3) cells, and His6 -Scc4 and Scc1-FLAG
were co-expressed from the pCDFScc4 and pScc1-FT vectors in E. coli T7 Express cells. The cultures
were first grown in LB medium to an optical density at 600 nm of 0.6, and the cells were transferred to
M9 minimal medium (with ammonium chloride or 15 N-ammonium chloride). The protein expression
was induced with 0.5 mM isopropyl β-d-1-thiogalactopyranoside (IPTG), and the cultures were grown
at 16 ◦ C with 250 rpm shaking for 16 h. The cells were harvested by centrifugation (4000× g, 15 min,
4 ◦ C) and lysed using a French pressure cell 3 times. The protein complexes were purified from the
clarified lysate using Ni-IMAC with 4 mL of resin and Tris buffer followed by SEC with NMR buffer.
The purified proteins were analyzed using SDS-PAGE and the Coomassie protein assay.
Co-expression cultures of the Scc4:His6 -Scc1 and His6 -Scc4:Scc1-FLAG complexes were used to
purify Scc4 and Scc1-FLAG and prepare immobilized His6 -Scc1 as described by Ukwaththage, et al. [22].
Briefly, the complexes were immobilized on 4 mL of Ni-IMAC resin, and 0.5% sarkosyl in Tris buffer
was used to dissociate the complexes and elute either Scc4 or Scc1-FLAG, leaving the His-tagged
proteins (His6 -Scc1 or His6 -Scc4) on the resin. The immobilized His6 -Scc1 was washed with Tris buffer
to remove residual sarkosyl. Sarkosyl was removed from the purified Scc4 and Scc1-FLAG proteins by
diluting the samples 5-fold with NMR buffer and exchanging the buffer to NMR buffer using centrifugal
filters. The purified proteins and the immobilized His6 -Scc1 were analyzed using SDS-PAGE, and the
purified Scc4 and Scc1-FLAG proteins were analyzed using the Commassie protein assay.
Scc4 and His6 -Scc1 were expressed individually in E. coli BL21-Gold (DE3) cells using the same
method as the expression of the Scc4:His6 -Scc1 and His6 -Scc4:Scc1-FLAG complexes. Scc4 in clarified
lysate and His6 -Scc1 inclusion bodies were prepared by suspending the harvested cells in 20 mL
of Tris buffer with 2 Pierce EDTA-free protease inhibitor mini tablets, 2.3 mL of 10X BugBuster
protein extraction reagent, and 1 µL of Benzonase nuclease and lysing with a French press (SLM
Instruments Inc./American Instrument Co., Urbana, IL, USA) 3 times. The Scc4 cell lysate was clarified
by centrifugation (25,000× g for 20 min at 4 ◦ C). His6 -Scc1 inclusion bodies were purified by washing
the lysed pellet with 20 mL each of 1× BugBuster in Tris buffer, 1X BugBuster in Tris buffer with
200 µg/mL of hen egg white lysozyme, and 1X BugBuster in Tris buffer using centrifugation at 15,000× g
for 20 min at 4 ◦ C to remove the supernatant between each step. The purified His6 -Scc1 inclusion
bodies were centrifuged at 25,000× g for 20 min at 4 ◦ C to remove residual supernatant and analyzed
using SDS-PAGE.
2.4. NMR Analysis
Protein samples were prepared in NMR buffer using SEC and centrifugal filters to a final
concentration of 0.35–0.5 mM. The samples were transferred to 5 mm D2 O-susceptibility matched
Shigemi tubes, and 5 µM sodium 3-(trimethylsilyl)-1-propanesulfonate (DSS) and 10% D2 O were
added for chemical shift referencing and locking, respectively. 1 H,15 N-Heteronuclear single quantum
coherence (HSQC) spectra were recorded on an Advance III HD 500 MHz instrument (Bruker Corp.,
Billerica, MA, USA) at 300 K (27 ◦ C) with 32–64 scans and 256 increments. Spectra were processed and
analyzed with Bruker Topspin software.
For the chemical shift perturbation analysis, 15 N-Scc4 was concentrated to 0.5 mM and transferred
to a 5 mm D2 O-susceptibility matched Shigemi tube. DSS (5 µM) and 10% D2 O were added for
chemical shift referencing and locking, respectively. Scc1-FLAG was concentrated to make two stock
solutions in NMR buffer: Stock 1 was 3.75 mM and Stock 2 was 7.5 mM. 1 H,15 N-HSCQ spectra were
collected on an Advance III HD 500 MHz instrument (Bruker Corp., Billerica, MA, USA) at 300 K
(27 ◦ C) with 8 scans and 256 increments. The 15 N-Scc4 sample was analyzed with increasing mole
fractions of Scc1-FLAG (0, 0.25, 0.5, 1.0, 1.5, and 2.0 moles of Scc1-FLAG to moles of 15 N-Scc4). Stock 1
was used for the 0.25 and 0.5 mole fraction additions of Scc1-FLAG, and Stock 2 was used to increase
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the mole fraction to 1.0, 1.5, and 2.0. The sample volume over the titration was 300–350 µL, which is
within the detectable region of the NMR probe such that dilution did not affect the signal intensities.
After each addition of Scc1-FLAG, the samples were incubated at room temperature for 30 min. For the
1:2 molar ratio (15 N-Scc4:Scc1-FLAG) sample, an additional HSQC spectrum was collected after the
sample was incubated overnight at 4 ◦ C. The chemical shift perturbation was calculated by adding the
combined chemical shift change [23] using a 15 N shift scaling factor of 0.14 for each step of the titration
(since the changes were non-linear).
2.5. On-Column Association of 15 N-Scc4 and His6 -Scc1
His6 -Scc1 immobilized on Ni-IMAC resin and samples of 15 N-Scc4 (purified or in clarified lysate)
were mixed to test complex formation. Purified 15 N-Scc4 or 15 N-Scc4 in clarified lysate were each
loaded onto the Ni-IMAC resin with immobilized His6 -Scc1. The sample that flowed through the
column was collected for SDS-PAGE analysis. The resin was washed with Tris buffer, and the proteins
were eluted with 500 mM imidazole in Tris buffer. SDS-PAGE analysis was used to determine if
15 N-Scc4 associated with His -Scc1 and eluted with imidazole or if 15 N-Scc4 failed to associate and
6
flowed through the column. The on-column associated complex from mixing 15 N-Scc4 in clarified
lysate with immobilized His6 -Scc1 was tested for stability over 2 days at room temperature and
compared to the stability of the in vivo-associated complex using native PAGE and qualitative SEC
analyses. The differences in the qualitative SEC elution times of the in vivo- and on-column-associated
complexes should not be interpreted quantitatively to measure molecular weight; because, while the 0
and 2 d complexes were analyzed 2 days apart and can be compared to assess stability of the complex,
the different complexes were analyzed weeks to months apart and the drift in the pump flow rates and
column condition were not corrected by calibration.
2.6. Renatured-Association of Scc4 and His6 -Scc1 with Chain Selective Labeling
Renatured-association of Scc4 and His6 -Scc1 involved diluting denatured His6 -Scc1 with refolding
buffer and adding it dropwise to clarified Scc4 lysate. Four different refolding buffers were tested.
The standard refolding buffer (Buffer 4) is 125 mM Tris, 175 mM NaCl, 10 mM DTT, and pH 7.7.
Additives to the standard buffer are 5 mM glutathione (GSH), 0.5 mM oxidized glutathione (GSSH),
and 5 M L-arginine (Buffer 1), 5 mM GSH and 0.5 mM GSSH (Buffer 2), and 5 M L-arginine (Buffer 3).
Purified His6 -Scc1 inclusion bodies from a 500 mL culture were denatured in 8 mL of 6 M guanidine
hydrochloride (GuHCl) in Buffer 4 by vortexing the solution until it became clear. Samples of the
denatured His6 -Scc1 (1 mL) were diluted by dropwise addition of 2 mL of each refolding buffer,
reducing the GuHCl concentration to 2 M. Clarified Scc4 lysate (23 mL) from a 1 L culture was split
into 4 aliquots of 5 mL. The diluted His6 -Scc1 samples were added dropwise to the clarified lysate
resulting in a final GuHCl concentration of 0.75 M. Each mixture was purified by Ni-IMAC using 1 mL
of resin and Tris buffer. The purified proteins were analyzed using SDS-PAGE and the Coomassie
protein assay.
Chain selectively labeled Scc4:His6 -Scc1 complexes (15 N-Scc4:His6 -Scc1 and Scc4:15 N-His6 -Scc1)
were prepared using the renaturing method described above with Buffer 4. Denatured His6 -Scc1
(or 15 N-His6 -Scc1) from a 500 mL culture (8 mL) was diluted with 16 mL of Buffer 4 and added dropwise
with vortexing to 23 mL of clarified 15 N-Scc4 (or Scc4) lysate from a 1 L culture (1.0 M final GuHCl
concentration). The protein mixtures were incubated for 10 min at room temperature and centrifuged
at 8000× g for 10 min at 4 ◦ C to remove any precipitated proteins. The clarified protein mixtures were
purified by Ni-IMAC using 3 mL of resin and phosphate buffer followed by SEC with NMR buffer.
The purified proteins were analyzed using SDS-PAGE and the Coomassie protein assay. The renatured
complex was tested for stability over 2 days at room temperature and compared to the stability of
the in vivo-associated complex using native PAGE and qualitative SEC analyses. The differences in
the qualitative SEC elution times of the in vivo-associated and renatured complexes should not be
interpreted quantitatively (refer to Section 2.5 for details).
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3. Results and Discussion
3.1. Crowded NMR Spectra of In Vivo-Associated, 15 N-labeled Scc4:Scc1 Complexes
In our previous work, we showed that Scc4 and Scc1 associate in vivo when co-expressed
in E. coli [16]. The interaction was strong allowing for the complex to be purified by Ni-IMAC
when either Scc4 or Scc1 had a His6 -tag. Two variations of the complex (different by their affinity
purification tags) were produced for crystallization trials, Scc4:His6 -Scc1 and His6 -Scc4:Scc1-FLAG,
with no crystals. As an alternative to X-ray crystallography for protein structure determination,
the suitability of the complexes for NMR structure determination was investigated. To this end,
15 N-labeled Scc4:His -Scc1 and His -Scc4:Scc1-FLAG complexes were produced by metabolic labeling
6
6
in E. coli using 15 N-supplemented minimal medium. The yields of the complexes from the minimal
media cultures were similar to the yields from LB media cultures [22] with 10–12 mg per L culture
for Scc4:His6 -Scc1 and 18–20 mg per L culture for His6 -Scc4:Scc1-FLAG. As expected, the purified
complexes showed a 1:1 molar ratio on an SDS-PAGE gel and eluted as a single peak in SEC, indicating
the successful purification of the in vivo-associated complexes (Figures S1 and S2).
In order to determine the structure of a protein or protein complex using NMR spectroscopy, the first
step is to evaluate the quality of the 1 H, 15 N-HSQC spectrum of the sample. In this spectrum, we expect
a peak for each amide group (except proline), which includes the amides along the backbone and in the
sidechains. If the protein is folded, we expect the peaks to be of similar intensity (similar peak widths)
and dispersed. The 1 H, 15 N-HSQC spectra of 15 N-labeled Scc4:His6 -Scc1 and His6 -Scc4:Scc1-FLAG are
shown in Figure 2A,B, respectively, and overlaid in Figure S3. As expected, the peak positions in each
spectrum are the same, indicating that the two complexes have the same fold, with the exception of a
subset of peaks likely belonging to the different purification tags. The Scc4:His6 -Scc1 spectrum has
better NMR spectral properties compared to the His6 -Scc4:Scc1-FLAG spectrum. The relative intensity
of the peaks for the Scc4:His6 -Scc1 complex (Figure 2A) is more uniform than the His6 -Scc4:Scc1-FLAG
complex (Figure 2B), and the Scc4:His6 -Scc1 complex has fewer peaks near the center of the spectrum
(Figure 2C,D). We have observed similar differences between 1 H,15 N-HSQC spectra of Scc4 and
His6 -Scc4, where the His6 -tag results in poorer quality spectra [22]. Similarly, the Scc1 purification tags,
the N-terminal His6 -tag and the C-terminal FLAG tag, may contribute to differences in the spectra.
In the Scc4:His6 -Scc1 spectrum, 298 peaks (out of an expected 364 peaks) were counted giving 82% of
the expected amide peaks (including sidechain peaks). While this percentage is an excellent result for
a relatively large complex (33.5 kDa), the large number of peaks and crowded region in the center of
the spectrum prevents unambiguous peak assignment, which is necessary for structure determination.
An alternative approach to using the fully 15 N-labeled complex is to selectively label each chain in the
complex such that one protein is visible in the NMR spectrum at a time reducing resonance overlap.
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Figure
S3. using a Bruker AVIII 500 MHz
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pH500
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and theOverlays
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with
scans
spectrometer.
Overlays of the spectra are shown in Figure S3.
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thebycomplex.
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complex on-column, we observed that the immobilized His6-Scc1 protein could be reused to capture
a chain-selectively
labeled complex, the two proteins must interact under conditions that allow for
Scc4 from lysate [22]. The on-column-associated complex was then eluted with imidazole buffer. This
stable association
the innative
strategyinto
(shown
Figurequaternary
3A) was used structure.
to produce the chain-selectively labeled complex, 15N6-Scc1.
3B shows
the SDS-PAGE
of the steps
the process of associating
Scc4:His
During our
work
to Figure
produce
tag-free
Scc4 by analysis
dissociating
theinco-expressed
Scc4:His15N6 -Scc1 complex
Scc4 with unlabeled His6-Scc1 on the Ni-IMAC column. Sarkosyl was used to dissociate unlabeled
on-column, we
observed that the immobilized His -Scc1 protein could be reused to capture Scc4 from
Scc4 from the immobilized Scc4:His6-Scc1 complex6 (Figure 3B, lane 5) leaving His6-Scc1 immobilized
lysate [22]. The
on-column-associated
complex
was
then eluted
with imidazole
buffer. This strategy
in clarified
lysate associated
with the immobilized
on the
Ni-IMAC resin (Figure 3B, lane
6). 15N-Scc4
15 N-Scc4:His
theused
complex
eluted with
imidazole (Figure 3B, lane
9). Interestingly,
the
His6-Scc1,
(shown in Figure
3A)and
was
to was
produce
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labeled
complex,when
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15
Figure 3B shows the SDS-PAGE analysis of the steps in the process of associating N-Scc4 with
unlabeled His6 -Scc1 on the Ni-IMAC column. Sarkosyl was used to dissociate unlabeled Scc4 from the
immobilized Scc4:His6 -Scc1 complex (Figure 3B, lane 5) leaving His6 -Scc1 immobilized on the Ni-IMAC
resin (Figure 3B, lane 6). 15 N-Scc4 in clarified lysate associated with the immobilized His6 -Scc1, and the
complex was eluted with imidazole (Figure 3B, lane 9). Interestingly, when the source of 15 N-Scc4
was in buffer, the chain-selectively labeled complex did not associate on-column (the 15 N-Scc4 flowed
through the resin (Figure 3C, lane 4) and the imidazole elution only contained His6 -Scc1 (Figure 3C,
lane 5)). The on-column association was performed with purified Scc4 in both phosphate and Tris
buffers with the same negative result [24], suggesting a role for lysate in the association. This role
could be fulfilled by a specific lysate component or a general matrix effect on the structures of Scc4
and/or His6 -Scc1 that facilitates binding [25].
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15N-Scc4. (A) Scheme for making chain-selectively labeled complex onin clarified lysate or purified
15
in clarified lysate or purified N-Scc4. (A) Scheme for making chain-selectively labeled complex
column. The unlabeled, in vivo-associated complex is (i) loaded onto Ni-IMAC resin and washed. (ii)
on-column. The
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labeled
components,
i.e.,containing
complex in (i) and unlabeled
expressed Scc4:His6-Scc1 complex are shown in lanes 1 and lane 2, respectively. The immobilization
Scc4 in (iii). of(B)
SDS-PAGE analysis of the on-column association of immobilized His -Scc1 and
His6-Scc1 onto Ni-IMAC resin is shown in lanes 3–6 with samples of the Scc4:His6-Scc1 lysate that 6
15 N-Scc4 in clarified lysate. Clarified lysate samples containing 15 N-Scc4 and unlabeled, co-expressed
flowed through the resin (lane 3), wash (lane 4), sarkosyl elution of Scc4 from the immobilized
Scc4:His6 -Scc1 complex are shown in lanes 1 and lane 2, respectively. The immobilization of His6 -Scc1
onto Ni-IMAC resin is shown in lanes 3–6 with samples of the Scc4:His6 -Scc1 lysate that flowed through
the resin (lane 3), wash (lane 4), sarkosyl elution of Scc4 from the immobilized Scc4:His6 -Scc1 complex
(lane 5), and Ni-IMAC resin with immobilized His6 -Scc1. On-column association of 15 N-Scc4 with
the immobilized His6 -Scc1 is shown in lanes 7-9 with the 15 N-Scc4 lysate that flowed through the
resin (lane 7), the wash (lane 8), and the imidazole elution of the 15 N-Scc4:His6 -Scc1 complex (lane 9).
(C) SDS-PAGE analysis of the on-column association using purified 15 N-Scc4 (lane 1) and co-expressed
Scc4:His6 -Scc1 (lane 2). Unlabeled Scc4 was eluted from the immobilized Scc4:His6 -Scc1 complex (lane
3). The Ni-IMAC resin was washed, and the purified 15 N-Scc4 sample was loaded onto the resin (the
sample that flowed through the resin is shown in lane 4). Lane 5 is the sample that eluted from the
Ni-IMAC resin using imidazole buffer. Scc4 (14.7 kDa) and His6 -Scc1 (18.8 kDa) bands are indicated
with an open and closed arrow head, respectively. Lane 10 in (B) and lane 6 in (C) are the Fisher
BioReagents EZ-Run Rec pre-stained protein ladder with molecular weights listed to the right in kDa.

The chain-selectively labeled complex made using 15 N-Scc4 in lysate was analyzed using NMR
and compared to the in vivo-associated complex to see if the native structure was reproduced using the

Scc4:His6-Scc1 complex (lane 5), and Ni-IMAC resin with immobilized His6-Scc1. On-column
association of 15N-Scc4 with the immobilized His6-Scc1 is shown in lanes 7-9 with the 15N-Scc4 lysate
that flowed through the resin (lane 7), the wash (lane 8), and the imidazole elution of the 15N-Scc4:His6Scc1 complex (lane 9). (C) SDS-PAGE analysis of the on-column association using purified 15N-Scc4
(lane 1) and co-expressed Scc4:His6-Scc1 (lane 2). Unlabeled Scc4 was eluted from the immobilized
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1480 6-Scc1 complex (lane 3). The Ni-IMAC resin was washed, and the purified 15N-Scc4 sample
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was loaded onto the resin (the sample that flowed through the resin is shown in lane 4). Lane 5 is the
sample that eluted from the Ni-IMAC resin using imidazole buffer. Scc4 (14.7 kDa) and His6-Scc1 (18.8
kDa) bands are indicated with an open
and
arrow head, respectively. Lane 10 in (B) and lane
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3.3. Purified Scc1-FLAG Interacts Weakly with Purified 15 N-Scc4 Inducing Global Changes
Since the on-column association method did not produce stable complexes, a simpler approach
was tested: expressing and purifying each protein separately and recombining them in vitro. For the
Scc4 and Scc1 proteins, Scc4 expresses well and is soluble, but Scc1 is insoluble when expressed
alone [16]. The only soluble form of Scc1 that our group has successfully produced using E. coli is
Scc1-FLAG after dissociation of the His6 -Scc4:Scc1-FLAG complex immobilized on Ni-IMAC resin [22].
To determine if soluble Scc1-FLAG (prepared by on-column dissociation) and Scc4 associate in vitro
to form the chain-selectively labeled 15 N-Scc4:Scc1-FLAG complex, 15 N-labeled Scc4 was titrated
with unlabeled Scc1-FLAG and monitored with NMR. To confirm that adequate time was given to
form the complex, the sample of 15 N-Scc4 mixed with 2X molar Scc1-FLAG was analyzed again after
24 h and the spectrum did not change. Figure 5A shows an overlay of the 1 H, 15 N-HSQC spectra
collected over the course of the titration (the individual spectra are shown in Figure S5). Nearly
all of the peaks show chemical shift perturbations that are small (combined chemical shift changes
< 0.4 ppm). Enlarged regions of the overlaid spectra are shown in Figure 5B–D to show the various peak
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FLAG after dissociation of the His6-Scc4:Scc1-FLAG complex immobilized on Ni-IMAC resin [22]. To
determine if soluble Scc1-FLAG (prepared by on-column dissociation) and Scc4 associate in vitro to
form the chain-selectively labeled 15N-Scc4:Scc1-FLAG complex, 15N-labeled Scc4 was titrated with
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induced unfolding [23]. We have not ruled out the possibility that the FLAG-tag contributes to the
15 N-HSQC spectrum of the His -Scc4:Scc1-FLAG complex (Figure 2B); however, the FLAG-tag does
complexity of the titration6 results, especially since the FLAG-tag may affect the quality of the 1H, 15N2B); however,
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Figure 5. Overlay of 1 H, 15 N-HSQC spectra of 15 N-Scc4 titrated with Scc1-FLAG. Relative moles of
Scc1-FLAG to 15 N-Scc4 added are 0 (orange), 0.25 (red), 0.5 (pink), 1.0 (purple), 1.5 (blue), and 2.0
(green). (A) The full spectra overlaid with boxes showing the expanded regions. (B–D) The expanded
regions of the overlaid spectra in (A) with black lines marking the chemical shift perturbation over
the course of the titration. The spectra were collected on a Bruker AVIII 500 MHz spectrometer with 8
scans for each spectrum, with the exception of the spectrum at 2.0 relative moles (green), which was
collected with 32 scans. The contour levels were corrected for the number of scans to allow for direct
comparison. Individual spectra are shown in Figure S5.

3.4. Renatured, Chain-Selectively Labeled Scc4:His6 -Scc1 Complexes Are Stable and Have
In-Vivo-Like Structure
Based on the results that the proteins did not associate properly when Scc1 was soluble (in buffer
or on-column) or insoluble in lysate (Appendix A, Figure A1), we sought to mix the two proteins with
Scc1 in a denatured state. Purified His6 -Scc1 inclusion bodies (Figure S7) were denatured and added
dropwise to clarified lysate containing Scc4 in a ratio of 1 part culture volume His6 -Scc1 to 3.5 parts
culture volume Scc4 (Appendix B). The renatured protein complex was purified using Ni-IMAC.

the course of the titration. The spectra were collected on a Bruker AVIII 500 MHz spectrometer with
8 scans for each spectrum, with the exception of the spectrum at 2.0 relative moles (green), which was
collected with 32 scans. The contour levels were corrected for the number of scans to allow for direct
comparison. Individual spectra are shown in Figure S5.
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Based on the results that the proteins did not associate properly when Scc1 was soluble (in buffer
or on-column) or insoluble in lysate (Appendix A, Figure A1), we sought to mix the two proteins
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Chain-selectively labeled 15 N-Scc4:His6 -Scc1 and Scc4:15 N-His6 -Scc1 were prepared using the
renaturing method for NMR analysis. In these experiments, 1 part culture volume of His6 -Scc1 was
mixed with 2 parts culture volume of 15 N-Scc4 to provide excess His6 -Scc1. The excess His6 -Scc1
ensured that all of the 15 N-Scc4 was bound (excess His6 -Scc1 precipitated and was removed by
centrifugation from the final mixture before Ni-IMAC purification). The SDS-PAGE analysis confirmed
the association of the 15 N-Scc4:His6 -Scc1 complex (Figure S9A, lane 7) in the Ni-IMAC elution. The yield
was 6–8 mg per L (of 15 N-Scc4) culture, which was comparable to the 10–12 mg per L culture of
co-expressed, in vivo-associated Scc4:His6 -Scc1 complex. The Scc4:15 N-His6 -Scc1 complex was made
using the same method with similar results (Figure S9B, lane 7) and a yield of 6–8 mg per L culture.
The imidazole elution samples for both complexes were further purified by SEC in the same manner as
the in vivo-associated complex (Figure S9A, lanes 9 and Figure S9B, lanes 9).
1 H,15 N HSQC spectra of the chain-selectively labeled complexes were collected and compared
to the spectrum of the in vivo-associated (fully 15 N-labeled) complex. To investigate any differences
between the renatured complexes and the in vivo-associated complex, the HSQC spectra were overlaid
to compare the peak positions and intensities. Figure 7A shows that over 97% of the peaks overlap
verifying that the two quaternary structures are the same and validating the suitability of the renaturing
method to pursue the high-resolution 3-dimensional structure of the complex by NMR.

L culture. The imidazole elution samples for both complexes were further purified by SEC in the
same manner as the in vivo-associated complex (Figure S9A, lanes 9 and Figure S9B, lanes 9).
1H,15N HSQC spectra of the chain-selectively labeled complexes were collected and compared to
the spectrum of the in vivo-associated (fully 15N-labeled) complex. To investigate any differences
between the renatured complexes and the in vivo-associated complex, the HSQC spectra were
overlaid to compare the peak positions and intensities. Figure 7A shows that over 97% of the peaks
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renaturing method to pursue the high-resolution 3-dimensional structure of the complex by NMR.
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Figure 7. 1H, 15N-HSQC spectra of in vivo-associated 15N-labeled Scc4:His6-Scc1 (black), renatured 15N-
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of the expected peaks for Scc4 and His6 -Scc1, respectively, with a total of 308 peaks. The total number
of peaks is consistent with the 298 peaks counted for the in vivo-associated complex with 10 additional
peaks identified due to the reduced resonance overlap. NMR analysis of the selectively labeled
complexes shows that Scc4 is well-structured in the complex with a high percentage of expected peaks
(Figure 8A), but 24% of the expected peaks for His6 -Scc1 (approximately 40 residues) have low intensity
or are missing (Figure 8B), indicating that a portion of His6 -Scc1 is dynamic. Based on our previous
work, the N-terminus of His6 -Scc1 (in the co-expressed Scc4:His6 -Scc1 complex), but not the C-terminus,
was susceptible to limited proteolysis (Figure 9, light purple) [16]. The His6 -tag and N-terminal Scc1
residues are likely the dynamic region with missing peaks in the NMR spectrum. This Scc1 N-terminal
region was also predicted to bind CopN (Figure 9) based on structural homology [16]. The dynamic
nature of the Scc1 N-terminus suggests that it binds CopN in an induced fit model, regulating CopN
recognition and release (secretion) by the T3SS chaperone complex. The chain-selective labeling
approach will allow future work to verify the identity of the missing His6 -Scc1 resonances, study CopN
recognition using NMR, and determine the high-resolution structures of Scc4 and His6 -Scc1 in
the complex.
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the NMR spectrum. This Scc1 N-terminal region was also predicted to bind CopN (Figure 9) based
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Figure 8. 1H, 15N-HSQC spectra of renatured (A,C) 15N-Scc4:His6-Scc1 and (B,D) Scc4:15N-His6-Scc1
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3.5. Different Structures for Scc4′s Different Functions
Scc4 [18].
One of the questions our group is pursuing is the mechanism by which Scc4 switches between
its functions as a T3SS chaperone and an RNAP-binding protein. During the developmental cycle,
Scc4 temporally binds Scc1/CopN and σ66RNAP, and the structure of Scc4 must accommodate
association into these two different complexes. Comparing the backbone structure of Scc4 with the
Scc4:Scc1 T3SS chaperone complex provides insight into the switching mechanism. From our
previous work with Scc4, the NMR resonance assignments, secondary structure, and disorder
parameters for Scc4 revealed a dynamic protein (56% random coil) with unassigned residues across
the sequence and disordered regions where Scc1 is predicted to bind Scc4 (Figure 9, light pink
residues) [18]. In contrast, the homology model of Scc4 constructed from the X-ray structures of other
T3SS chaperone complexes in Figure 9 predicted a compact tertiary structure with few random coil
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3.5. Different Structures for Scc40 s Different Functions
One of the questions our group is pursuing is the mechanism by which Scc4 switches between
its functions as a T3SS chaperone and an RNAP-binding protein. During the developmental cycle,
Scc4 temporally binds Scc1/CopN and σ66 RNAP, and the structure of Scc4 must accommodate
association into these two different complexes. Comparing the backbone structure of Scc4 with the
Scc4:Scc1 T3SS chaperone complex provides insight into the switching mechanism. From our previous
work with Scc4, the NMR resonance assignments, secondary structure, and disorder parameters for
Scc4 revealed a dynamic protein (56% random coil) with unassigned residues across the sequence and
disordered regions where Scc1 is predicted to bind Scc4 (Figure 9, light pink residues) [18]. In contrast,
the homology model of Scc4 constructed from the X-ray structures of other T3SS chaperone complexes
in Figure 9 predicted a compact tertiary structure with few random coil regions (35% random coil) [16].
In Figure 10, the 1 H, 15 N-HSQC spectra of Scc4 and 15 N-Scc4:His6 -Scc1 are shown and overlaid for
comparison. Comparing Figure 10A,C, Scc4 in the complex, 15 N-Scc4:His6 -Scc1, has a larger peak
dispersion, more peaks, and more uniform peak intensity compared to Scc4 alone. All three of these
characteristics indicate that Scc4 in the complex has more residues participating in structural elements
with fewer regions of local mobility on the ms to µs timescale (broad peaks) and fewer dynamic,
unstructured regions with sub-ns timescale motions (sharp, high intensity peaks) [28]. With 97% of
the expected peak count in the 15 N-Scc4:His6 -Scc1 spectrum, the disordered regions of Scc4 clearly
became well-structured in the T3SS chaperone complex. The overlaid spectra (Figure 10E,F) show very
little (<15%) peak overlap, indicating that at least 85% of the backbone structures of Scc4 (free and
bound) are completely different. This result is surprising considering only 28% of Scc40 s residues
are predicted to be within 5Å of the Scc1 interface (Figure S13). Even if the assumption is made
that the overlapping 15 N-Scc4:His6 -Scc1 peaks have the same resonance assignments as Scc4 alone,
the residues assigned to these peaks do not cluster to a specific region of the protein when mapped
onto the homology model (Figure S13) as would be expected if part of the structure was unchanged.
Given the extent and fragmented nature of the peak shifts, it can be concluded that the entire tertiary
structure of Scc4 changed upon binding Scc1. These results are consistent with the NMR-derived
dynamic regions of Scc4 (Figure 9, light pink residues) becoming structured upon binding Scc1 as
predicted by the T3SS chaperone homology model (Figure 9, all pink residues). This elasticity allows
Scc4 to change its structure and bind different complexes depending on the availability of its binding
partners. It also explains why CopN does not bind Scc4, but only Scc4 in complex with Scc1. Unlike
the disordered region of Scc1 that was predicted to bind CopN, the Scc4 predicted-interface with CopN
is well-structured like a lock-and-key binding model.

expected if part of the structure was unchanged. Given the extent and fragmented nature of the peak
shifts, it can be concluded that the entire tertiary structure of Scc4 changed upon binding Scc1. These
results are consistent with the NMR-derived dynamic regions of Scc4 (Figure 9, light pink residues)
becoming structured upon binding Scc1 as predicted by the T3SS chaperone homology model (Figure
9, all pink residues). This elasticity allows Scc4 to change its structure and bind different complexes
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Figure 10. 1 H, 15 N-HSQC spectra of (A,B) 15 N-Scc4 and (C,D) Scc4 in the 15 N-Scc4:His6 -Scc1 renatured
complex. (E,F) Overlay of the 1 H,15 N-HSQC spectra of 15 N-Scc4 (blue) and Scc4 in the 15 N-Scc4:His6 -Scc1
renatured complex (pink). (B,D,F) Expanded regions from dashed boxes in (A,C,E), respectively.

4. Conclusions
The results from this work provide an approach for producing chain-selectively labeled
Scc4:His6 -Scc1 complex for NMR analysis and new models for Scc4 and Scc1 association, Scc40 s
switching mechanism, and CopN recognition. The labeling approach was sucessful in producing the
complex with the correct structure and in yields (6–8 mg per L culture) sufficient for NMR analysis.
The reduced resonance overlap allows the pursuit of the Scc4:Scc1 T3SS complex structure by NMR.
Analysis of the chain-selectively labeled complexes provided new information on the nature of each
protein in the complex. Scc1 has a dynamic region hypothesized to be the N-terminal region and bind
CopN. Conversely, Scc4 was well-structured in the complex compared to its highly dynamic free form,
and the backbone structure of Scc4 completely changed upon binding Scc1. The molecular mechanisms
of this structural switch can now be studied using the chain selective labeling approach.

Figure 10. 1H, 15N-HSQC spectra of (A,B) 15N-Scc4 and (C,D) Scc4 in the 15N-Scc4:His6-Scc1 renatured
complex. (E,F) Overlay of the 1H,15N-HSQC spectra of 15N-Scc4 (blue) and Scc4 in the 15N-Scc4:His6Scc1 renatured complex (pink). (B,D,F) Expanded regions from dashed boxes in (A,C,E), respectively.
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The results from this work provide an approach for producing chain-selectively labeled
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Scc4:His6-Scc1 complex for NMR analysis and new models for Scc4 and Scc1 association, Scc4′s
switching mechanism, and CopN recognition. The labeling approach was sucessful in producing the
complex with the correct structure and in yields (6–8 mg per L culture) sufficient for NMR analysis.
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Figure 11. Working model of Scc40 s functional switch from a transcription factor to a T3SS chaperone
Figure 11. Working model of Scc4′s functional switch from a transcription factor to a T3SS chaperone
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Appendix B
Inclusion bodies of His6 -Scc1 from a 500 mL expression culture of E. coli were purified (Figure S7)
and denatured in 6 M GuHCl Tris buffer. The concentration of GuHCl was diluted with buffer to
a final concentration of 2 M, which was determined to be the minimum concentration necessary to
maintain His6 -Scc1 solubility (based on visual turbidity). The denatured, soluble His6 -Scc1 was added
dropwise to clarified lysate containing Scc4. Ideally, equal moles of His6 -Scc1 and Scc4 would be
mixed, but the concentrations of the proteins could not be determined due to the complicated sample
matrix. The expression of His6 -Scc1 alone typically has a higher yield than Scc4, so we related the
concentrations of the proteins to the culture volumes, which was 1 part His6 -Scc1 to 3.5 parts Scc4.
After His6 -Scc1 was added to Scc4, the final concentration of GuHCl was 0.75 M and the mixture
was purified using Ni-IMAC. Figure A2 shows the SDS-PAGE results of testing four buffers (refer to
Section 2.6 for details) to dilute the denatured His6 -Scc1 protein solutions before mixing with the Scc4
lysate. The Ni-IMAC elution samples showed successful association of the Scc4:His6 -Scc1 complex with
a 1:1 molar ratio and similar yields for all buffers (Figure A2, lanes 3–6). The additional components of
GSH/GSSG and l-arginine to the buffer did not impact the association.
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Appendix
C
Over 97% of the peaks in the HSQC spectra of the renatured complexes overlap with peaks of

Appendix C the in vivo-associated complex (Figures 7A and 7B). The few exceptions are highlighted in Figure A3.
Three peaks in the spectra have small chemical shift differences such that the peaks do not overlap
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His6 -Scc1). Finally, there are two peaks in the 15 N-Scc4:His6 -Scc1 spectrum (vi and viii) and one peak
in the in vivo-associated complex spectrum (ix) that do not have an obvious counterpart. Overall,
these data indicate minor differences in the overall structure and dynamics of the complexes. We plan
to identify and characterize these differences in the future by assigning the backbone resonances of the
renatured complexes.
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